References: Content provided by our partner site, Managed Healthcare Executive.
Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More ByRihards Buss, MD,Jack Arnold, MBBS, MRCP, PhDJuly 16th 2026
Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MDByFrank Behrens, MDJuly 15th 2026
What We're Looking Forward to in Rheumatology in H2 2026ByRheumatologyLive Editorial StaffJuly 8th 2026
Obesity and GLP-1 RAs: Why TOGETHER-PsA Matters, With Philip Mease, MDByPhilip J. Mease, MDJuly 1st 2026